1-5 of 5
Chinthalapally V. Rao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

DCLK1-Isoform2 Alternative Splice Variant Promotes Pancreatic Tumor Immunosuppressive M2-Macrophage Polarization

Parthasarathy Chandrakesan, Janani Panneerselvam, Randal May, Nathaniel Weygant, Dongfeng Qu, William R. Berry, Kamille Pitts, Ben Z. Stanger, Chinthalapally V. Rao, Michael S. Bronze, Courtney W. Houchen
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2020) 19 (7): 1539–1549.
https://doi.org/10.1158/1535-7163.MCT-19-0776
Published: 02 July 2020
View article titled, DCLK1-Isoform2 Alternative Splice Variant Promotes Pancreatic Tumor Immunosuppressive M2-Macrophage Polarization
Open the PDF for DCLK1-Isoform2 Alternative Splice Variant Promotes Pancreatic Tumor Immunosuppressive M2-Macrophage Polarization in another window
Includes: Supplementary data
Journal Articles

β-Ionone inhibits colonic aberrant crypt foci formation in rats, suppresses cell growth, and induces retinoid X receptor-α in human colon cancer cells

Naveena B. Janakiram, Indranie Cooma, Altaf Mohammed, Vernon E. Steele, Chinthalapally V. Rao
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (1): 181–190.
https://doi.org/10.1158/1535-7163.MCT-07-0529
Published: 17 January 2008
View article titled, β-Ionone inhibits colonic aberrant crypt foci formation in rats, suppresses cell growth, and induces retinoid X receptor-α in human colon cancer cells
Open the PDF for β-Ionone inhibits colonic aberrant crypt foci formation in rats, suppresses cell growth, and induces retinoid X receptor-α in human colon cancer cells in another window
Journal Articles

β-Escin inhibits colonic aberrant crypt foci formation in rats and regulates the cell cycle growth by inducing p21waf1/cip1 in colon cancer cells

Jagan M.R. Patlolla, Jayadev Raju, Malisetty V. Swamy, Chinthalapally V. Rao
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (6): 1459–1466.
https://doi.org/10.1158/1535-7163.MCT-05-0495
Published: 03 July 2006
View article titled, β-Escin inhibits colonic aberrant crypt foci formation in rats and regulates the cell cycle growth by inducing p21<sup>waf1/cip1</sup> in colon cancer cells
Open the PDF for β-Escin inhibits colonic aberrant crypt foci formation in rats and regulates the cell cycle growth by inducing p21<sup>waf1/cip1</sup> in colon cancer cells in another window
Journal Articles

Nitric oxide–releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets

Chinthalapally V. Rao, Bandaru S. Reddy, Vernon E. Steele, C-X Wang, Xiaoping Liu, Nengtai Ouyang, Jagan M.R. Patlolla, Barbara Simi, Levy Kopelovich, Basil Rigas
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (6): 1530–1538.
https://doi.org/10.1158/1535-7163.MCT-06-0061
Published: 03 July 2006
View article titled, Nitric oxide–releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets
Open the PDF for Nitric oxide–releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets in another window
Journal Articles

Modulation of cyclooxygenase-2 activities by the combined action of celecoxib and decosahexaenoic acid: Novel strategies for colon cancer prevention and treatment

Malisetty V. Swamy, Indranie Cooma, Jagan M.R. Patlolla, Barbara Simi, Bandaru S. Reddy, Chinthalapally V. Rao
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2004) 3 (2): 215–221.
https://doi.org/10.1158/1535-7163.215.3.2
Published: 25 February 2004
View article titled, Modulation of cyclooxygenase-2 activities by the combined action of celecoxib and decosahexaenoic acid: Novel strategies for colon cancer prevention and treatment
Open the PDF for Modulation of cyclooxygenase-2 activities by the combined action of celecoxib and decosahexaenoic acid: Novel strategies for colon cancer prevention and treatment in another window